Medifast Inc
MED
Market Cap$155.3M
Close$
$41.67
213.1% upside
Current Fair Value
213.1% upsideUndervalued by 213.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $155.30 Million |
|---|---|
| Enterprise Value | $72.37 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0.19 |
| Beta | 0.89 |
| Outstanding Shares | 10,948,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -22.11 |
|---|---|
| PEG | 20.23 |
| Price to Sales | 0.27 |
| Price to Book Ratio | 0.7 |
| Enterprise Value to Revenue | 0.13 |
| Enterprise Value to EBIT | -11.6 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Medifast Inc
550 employees
CEO: Daniel Chard Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and ...